Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 5/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SI | P14410 | 1/20 | 0.35 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7519688 | 0.96 | — | — | |
| SCHEMBL7627644 | 0.92 | ALDH1A1 (0.47) | ALDH1A1CA1NPSR1TSHRKEAP1 | |
| SCHEMBL7042120 | 0.92 | — | — | |
| SCHEMBL10490552 | 0.92 | ALDH1A1 (0.47) | ALDH1A1CA1NPSR1TSHRKEAP1 | |
| Potassium Ion SCHEMBL1007640 | 0.92 | — | — | |
| SCHEMBL1681011 | 0.92 | ALDH1A1 (0.47) | ALDH1A1CA1NPSR1TSHRKEAP1 | |
| Potassium Ion SCHEMBL11850339 | 0.92 | CA4 (0.47) | ALDH1A1CA1NPSR1TSHRKEAP1 | |
| Lithium Ion SCHEMBL6352034 | 0.92 | — | — | |
| SCHEMBL4754719 | 0.92 | — | — | |
| SCHEMBL7045610 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107466289-B | Process for producing ethylenically unsaturated carboxylic acids or esters | 三菱化学英国有限公司 | 2021-09-17 | — | — | CN | claimed |
| EP-3283456-B1 | A PROCESS FOR THE PRODUCTION OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACIDS OR ESTERS | MITSUBISHI CHEMICAL UK LTD (GB) | 2021-06-23 | — | — | EP | claimed |
| US-10464875-B2 | Process for the production of ethylenically unsaturated carboxylic acids or esters | LUCITE INTERNATIONAL UK LIMITED (GB) | 2019-11-05 | — | — | US | claimed |
| US-20180093937-A1 | PROCESS FOR THE PRODUCTION OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACIDS OR ESTERS | Mitsubishi Chemical UK Limited (GB) | 2018-04-05 | — | — | US | claimed |
| EP-3283456-A1 | A PROCESS FOR THE PRODUCTION OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACIDS OR ESTERS | Lucite International UK Limited (GB) | 2018-02-21 | — | — | EP | claimed |
| WO-2016166525-A1 | A PROCESS FOR THE PRODUCTION OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACIDS OR ESTERS | LUCITE INTERNATIONAL UK LIMITED (GB) | 2016-10-20 | — | — | WO | claimed |
| EP-3526191-B1 | A PROCESS FOR THE PRODUCTION OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACID ESTERS AND A CATALYST THEREFOR | MITSUBISHI CHEMICAL UK LTD (GB) | 2024-05-22 | — | — | EP | disclosed |
| CN-110382454-B | Process for producing ethylenically unsaturated carboxylic acid esters and catalyst therefor | 三菱化学英国有限公司 | 2023-05-30 | — | — | CN | disclosed |
| EP-3283456-B1 | A PROCESS FOR THE PRODUCTION OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACIDS OR ESTERS | MITSUBISHI CHEMICAL UK LTD (GB) | 2021-06-23 | — | — | EP | disclosed |
| US-10683255-B2 | Process for the production of ethylenically unsaturated carboxylic acid esters and a catalyst therefor | LUCITE INTERNATIONAL UK LIMITED (GB) | 2020-06-16 | — | — | US | disclosed |
| US-10464875-B2 | Process for the production of ethylenically unsaturated carboxylic acids or esters | LUCITE INTERNATIONAL UK LIMITED (GB) | 2019-11-05 | — | — | US | disclosed |
| EP-3526191-A1 | A PROCESS FOR THE PRODUCTION OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACID ESTERS AND A CATALYST THEREFOR | Lucite International UK Limited (GB) | 2019-08-21 | — | — | EP | disclosed |
| WO-2018069702-A1 | A PROCESS FOR THE PRODUCTION OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACID ESTERS AND A CATALYST THEREFOR | LUCITE INTERNATIONAL UK LIMITED (GB) | 2018-04-19 | — | — | WO | disclosed |
| US-20180093937-A1 | PROCESS FOR THE PRODUCTION OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACIDS OR ESTERS | Mitsubishi Chemical UK Limited (GB) | 2018-04-05 | — | — | US | disclosed |
| EP-3283456-A1 | A PROCESS FOR THE PRODUCTION OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACIDS OR ESTERS | Lucite International UK Limited (GB) | 2018-02-21 | — | — | EP | disclosed |
| WO-2016166525-A1 | A PROCESS FOR THE PRODUCTION OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACIDS OR ESTERS | LUCITE INTERNATIONAL UK LIMITED (GB) | 2016-10-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10464875-B2 | Process for the production of ethylenically unsaturated carboxylic acids or esters | ELOVL1, ELOVL5, FASN | ALDH1A1 273/4885CA1 146/4885NPSR1 3409/4885 |
| US-10683255-B2 | Process for the production of ethylenically unsaturated carboxylic acid esters and a catalyst therefor | MCCC2, FAR1, HADHB | ALDH1A1 1006/4885CA1 99/4885NPSR1 3914/4885 |
| US-20180093937-A1 | PROCESS FOR THE PRODUCTION OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACIDS OR ESTERS | ELOVL1, ELOVL5, FASN | ALDH1A1 276/4885CA1 160/4885NPSR1 3383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.